Cargando…
Pioglitazone, a PPAR-γ Activator, Stimulates BK(Ca) but Suppresses IK(M) in Hippocampal Neurons
Pioglitazone (PIO), a thiazolidinedone, was reported to stimulate peroxisome proliferator-activated receptor-γ (PPAR-γ) with anti-inflammatory, anti-proliferative, anti-diabetic, and antidepressive activities. However, whether this compound exerts any perturbations on Ca(2+)-activated K(+) and M-typ...
Autores principales: | Chen, Tsang-Shan, Lai, Ming-Chi, Hung, Te-Yu, Lin, Kao-Min, Huang, Chin-Wei, Wu, Sheng-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123368/ https://www.ncbi.nlm.nih.gov/pubmed/30210346 http://dx.doi.org/10.3389/fphar.2018.00977 |
Ejemplares similares
-
Doxorubicin resistance in breast cancer is mediated via the activation of FABP5/PPARγ and CaMKII signaling pathway
por: Chen, Nan-Nan, et al.
Publicado: (2023) -
The Pioglitazone Trek via Human PPAR Gamma: From Discovery to a Medicine at the FDA and Beyond
por: Devchand, Pallavi R., et al.
Publicado: (2018) -
Pioglitazone Inhibits Diabetes-Induced Atrial Mitochondrial Oxidative Stress and Improves Mitochondrial Biogenesis, Dynamics, and Function Through the PPAR-γ/PGC-1α Signaling Pathway
por: Zhang, Zhiwei, et al.
Publicado: (2021) -
Effects of the γ-secretase inhibitor semagacestat on hippocampal neuronal network oscillation
por: Hajós, Mihály, et al.
Publicado: (2013) -
PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients
por: Di Donfrancesco, Alessia, et al.
Publicado: (2023)